1. Nazari Mehrabani, Seyede Zahra, Shushizadeh, Mohammad Hossein, Abazari, Mohammad Foad, Abdollahzadeh, Rasoul, Azarnezhad, Asaad. 2018. Association of SHMT1, MAZ, ERG, and L3MBTL3 Gene Polymorphisms with Susceptibility to Multiple Sclerosis. In Biochemical genetics, 57, 355-370. doi:10.1007/s10528-018-9894-1. https://pubmed.ncbi.nlm.nih.gov/30456721/
2. Yang, Yang, Zhang, Minghui, Zhao, Yaxuan, Tian, Geng, Zhang, Yin. 2023. HOXD8 suppresses renal cell carcinoma growth by upregulating SHMT1 expression. In Cancer science, 114, 4583-4595. doi:10.1111/cas.15982. https://pubmed.ncbi.nlm.nih.gov/37752684/
3. Situ, Yongli, Zhang, Juying, Liao, Wenyu, Shao, Zheng, Deng, Li. . SHMT as a Potential Therapeutic Target for Renal Cell Carcinoma. In Frontiers in bioscience (Landmark edition), 28, 196. doi:10.31083/j.fbl2809196. https://pubmed.ncbi.nlm.nih.gov/37796681/
4. Beaudin, Anna E, Abarinov, Elena V, Noden, Drew M, Allen, Robert H, Stover, Patrick J. 2011. Shmt1 and de novo thymidylate biosynthesis underlie folate-responsive neural tube defects in mice. In The American journal of clinical nutrition, 93, 789-98. doi:10.3945/ajcn.110.002766. https://pubmed.ncbi.nlm.nih.gov/21346092/
5. Bahari, G, Hashemi, M, Naderi, M, Sadeghi-Bojd, S, Taheri, M. 2016. Association of SHMT1 gene polymorphisms with the risk of childhood acute lymphoblastic leukemia in a sample of Iranian population. In Cellular and molecular biology (Noisy-le-Grand, France), 62, 45-51. doi:. https://pubmed.ncbi.nlm.nih.gov/26950450/
智鼠故事 
